LABCORP HOLDINGS INC. Revenue
LABCORP HOLDINGS INC. (LH) reported Revenue of $3.73 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-08-05
- LABCORP HOLDINGS INC. revenues for the quarter ending 2026-06-30 was $3.73B, a 5.78% increase year-over-year.
- LABCORP HOLDINGS INC. revenues for the quarter ending 2026-03-31 was $3.54B, a 5.75% increase year-over-year.
- LABCORP HOLDINGS INC. revenues for the quarter ending 2025-12-31 was $3.52B, a 5.60% increase year-over-year.
- LABCORP HOLDINGS INC. revenues for the quarter ending 2025-09-30 was $3.56B, a 8.58% increase year-over-year.
- LABCORP HOLDINGS INC. revenues for fiscal 2025 was $13.95B, a 7.25% increase from fiscal 2024.
- LABCORP HOLDINGS INC. revenues for fiscal 2024 was $13.01B, a 6.97% increase from fiscal 2023.
- LABCORP HOLDINGS INC. revenues for fiscal 2023 was $12.16B, a 2.51% increase from fiscal 2022.
- LABCORP HOLDINGS INC. revenues for fiscal 2022 was $11.86B, a 9.68% decline from fiscal 2021.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 9 month as first filed | Revenues 12 month | Revenues 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.73B 10-Q · filed 2026-08-05 | $7.27B 10-Q · filed 2026-08-05 | $10.78B derived: sum of 3 quarters · filed 2026-08-05 | $14.35B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $3.54B 10-Q · filed 2026-05-04 | $7.05B derived: sum of 2 quarters · filed 2026-05-04 | $10.62B derived: sum of 3 quarters · filed 2026-05-04 | $14.14B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $3.52B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $7.08B derived: sum of 2 quarters · filed 2026-02-24 | $10.61B derived: sum of 3 quarters · filed 2026-08-05 | $13.95B 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $3.56B 10-Q · filed 2025-10-31 | $7.09B derived: sum of 2 quarters · filed 2026-08-05 | $10.44B 10-Q · filed 2025-10-31 | $13.77B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $3.53B 10-Q · filed 2026-08-05 | $6.87B 10-Q · filed 2026-08-05 | $10.20B derived: sum of 3 quarters · filed 2026-08-05 | $13.48B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $3.35B 10-Q · filed 2026-05-04 | $6.67B derived: sum of 2 quarters · filed 2026-05-04 | $9.96B derived: sum of 3 quarters · filed 2026-05-04 | $13.18B derived: sum of 4 quarters · filed 2026-05-04 | ||||
| 2024-12-31 | $3.33B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $6.61B derived: sum of 2 quarters · filed 2026-02-24 | $9.83B derived: sum of 3 quarters · filed 2026-02-24 | $13.01B 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $3.28B 10-Q · filed 2025-10-31 | $6.50B derived: sum of 2 quarters · filed 2025-10-31 | $9.68B 10-Q · filed 2025-10-31 | $12.71B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $3.22B 10-Q · filed 2025-08-01 | $6.40B 10-Q · filed 2025-08-01 | $9.43B derived: sum of 3 quarters · filed 2026-02-24 | $12.49B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | $3.18B 10-Q · filed 2025-04-29 | $6.21B derived: sum of 2 quarters · filed 2026-02-24 | $9.27B derived: sum of 3 quarters · filed 2026-02-24 | $12.30B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $3.03B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $6.09B derived: sum of 2 quarters · filed 2026-02-24 | $9.12B derived: sum of 3 quarters · filed 2026-02-24 | $12.16B 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $3.06B 10-Q · filed 2024-10-29 | $6.09B derived: sum of 2 quarters · filed 2024-10-29 | $9.13B 10-Q · filed 2024-10-29 | $12.06B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | $3.03B 10-Q · filed 2024-08-02 | $6.07B 10-Q · filed 2024-08-02 | $9.00B derived: sum of 3 quarters · filed 2025-02-25 | $11.87B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-03-31 | $3.04B 10-Q · filed 2024-04-30 | $3.78B 10-Q · filed 2023-05-04 | $5.97B derived: sum of 2 quarters · filed 2025-02-25 | $8.83B derived: sum of 3 quarters · filed 2025-02-25 | $11.76B derived: sum of 4 quarters · filed 2025-02-25 | |||
| 2022-12-31 | $2.93B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $5.80B derived: sum of 2 quarters · filed 2025-02-25 | $8.72B derived: sum of 3 quarters · filed 2025-02-25 | $11.86B 10-K · filed 2025-02-25 | $14.88B 10-K · filed 2023-02-28 | |||
| 2022-09-30 | $2.87B 10-Q · filed 2023-10-30 | $3.61B 10-Q · filed 2022-11-01 | $5.79B derived: sum of 2 quarters · filed 2023-10-30 | $8.93B 10-Q · filed 2023-10-30 | $11.20B 10-Q · filed 2022-11-01 | $10.76B derived: sum of 4 quarters · filed 2024-02-26 | ||
| 2022-06-30 | $2.92B 10-Q · filed 2023-08-04 | $3.70B 10-Q · filed 2022-08-01 | $6.07B 10-Q · filed 2023-08-04 | $7.60B 10-Q · filed 2022-08-01 | $7.89B derived: sum of 3 quarters · filed 2024-02-26 | $11.96B derived: sum of 4 quarters · filed 2024-02-26 | ||
| 2022-03-31 | $3.90B 10-Q · filed 2023-05-04 | $4.97B derived: sum of 2 quarters · filed 2024-02-26 | $9.03B derived: sum of 3 quarters · filed 2024-02-26 | $12.87B derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2021-12-31 | $1.07B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $5.13B derived: sum of 2 quarters · filed 2024-02-26 | $8.97B derived: sum of 3 quarters · filed 2024-02-26 | $13.14B 10-K · filed 2024-02-26 | $16.12B 10-K · filed 2022-02-25 | |||
| 2021-09-30 | $4.06B 10-Q · filed 2022-11-01 | $7.90B derived: sum of 2 quarters · filed 2022-11-01 | $12.06B 10-Q · filed 2022-11-01 | $16.55B derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $3.84B 10-Q · filed 2022-08-01 | $8.00B 10-Q · filed 2022-08-01 | $12.49B derived: sum of 3 quarters · filed 2023-02-28 | $16.39B derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $4.16B 10-Q · filed 2022-04-29 | $8.65B derived: sum of 2 quarters · filed 2023-02-28 | $12.55B derived: sum of 3 quarters · filed 2023-02-28 | $15.32B derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $4.49B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $8.39B derived: sum of 2 quarters · filed 2023-02-28 | $11.15B derived: sum of 3 quarters · filed 2023-02-28 | $13.98B 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $3.90B 10-Q · filed 2021-11-02 | $6.66B derived: sum of 2 quarters · filed 2021-11-02 | $9.49B 10-Q · filed 2021-11-02 | $12.44B derived: sum of 4 quarters · filed 2021-11-02 | ||||
| 2020-06-30 | $2.77B 10-Q · filed 2021-08-05 | $5.59B 10-Q · filed 2021-08-05 | $8.55B derived: sum of 3 quarters · filed 2021-08-05 | $11.47B derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $2.82B 10-Q · filed 2021-05-04 | $5.78B derived: sum of 2 quarters · filed 2021-05-04 | $8.71B derived: sum of 3 quarters · filed 2021-05-04 | $11.59B derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-12-31 | $2.95B 10-K · filed 2020-02-28 | $5.88B derived: sum of 2 quarters · filed 2020-10-29 | $8.76B derived: sum of 3 quarters · filed 2020-10-29 | $11.55B 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $2.93B 10-Q · filed 2020-10-29 | $5.81B derived: sum of 2 quarters · filed 2020-10-29 | $8.60B 10-Q · filed 2020-10-29 | $11.39B derived: sum of 4 quarters · filed 2020-10-29 | ||||
| 2019-06-30 | $2.88B 10-Q · filed 2020-07-31 | $5.67B 10-Q · filed 2020-07-31 | $8.46B derived: sum of 3 quarters · filed 2020-07-31 | $11.29B derived: sum of 4 quarters · filed 2020-07-31 | ||||
| 2019-03-31 | $2.79B 10-Q · filed 2020-05-08 | $5.58B derived: sum of 2 quarters · filed 2020-05-08 | $8.41B derived: sum of 3 quarters · filed 2020-05-08 | $11.28B derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | $2.79B 10-K · filed 2020-02-28 | $5.62B derived: sum of 2 quarters · filed 2020-02-28 | $8.49B derived: sum of 3 quarters · filed 2020-02-28 | $11.33B 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $2.83B 10-K · filed 2020-02-28 | $5.70B derived: sum of 2 quarters · filed 2020-02-28 | $8.55B 10-Q · filed 2019-10-31 | $11.29B derived: sum of 4 quarters · filed 2020-02-28 | ||||
| 2018-06-30 | $2.87B 10-K · filed 2020-02-28 | $5.71B 10-Q · filed 2019-08-08 | $8.46B derived: sum of 3 quarters · filed 2020-02-28 | $11.08B derived: sum of 4 quarters · filed 2020-02-28 | ||||
| 2018-03-31 | $2.85B 10-K · filed 2020-02-28 | $5.59B derived: sum of 2 quarters · filed 2020-02-28 | $8.21B derived: sum of 3 quarters · filed 2020-02-28 | $10.74B derived: sum of 4 quarters · filed 2020-02-28 | ||||
| 2017-12-31 | $2.74B 10-K · filed 2019-02-28 | $5.37B derived: sum of 2 quarters · filed 2019-02-28 | $7.89B derived: sum of 3 quarters · filed 2019-02-28 | $10.31B 10-K · filed 2020-02-28 | $10.44B 10-K · filed 2018-02-27 | |||
| 2017-09-30 | $2.62B 10-K · filed 2019-02-28 | $2.66B 10-Q · filed 2017-11-02 | $5.15B derived: sum of 2 quarters · filed 2019-02-28 | $7.56B 10-Q · filed 2018-10-30 | $7.65B 10-Q · filed 2017-11-02 | $9.90B derived: sum of 4 quarters · filed 2019-02-28 | ||
| 2017-06-30 | $2.53B 10-K · filed 2019-02-28 | $2.54B 10-Q · filed 2017-08-02 | $4.94B 10-Q · filed 2018-07-27 | $4.99B 10-Q · filed 2017-08-02 | $7.28B derived: sum of 3 quarters · filed 2019-02-28 | $9.70B derived: sum of 4 quarters · filed 2019-02-28 | ||
| 2017-03-31 | $2.41B 10-K · filed 2019-02-28 | $2.45B 10-Q · filed 2017-04-28 | $4.75B derived: sum of 2 quarters · filed 2019-02-28 | $7.17B derived: sum of 3 quarters · filed 2019-02-28 | $9.60B derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2016-12-31 | $2.34B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $4.75B derived: sum of 2 quarters · filed 2019-02-28 | $7.18B derived: sum of 3 quarters · filed 2019-02-28 | $9.55B 10-K · filed 2019-02-28 | $9.64B 10-K · filed 2017-02-27 | |||
| 2016-09-30 | $2.41B 10-Q · filed 2017-11-02 | $4.85B derived: sum of 2 quarters · filed 2017-11-02 | $7.21B 10-Q · filed 2017-11-02 | $16.79B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $2.43B 10-Q · filed 2017-08-02 | $4.80B 10-Q · filed 2017-08-02 | $14.37B derived: sum of 3 quarters · filed 2018-02-27 | $16.69B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $9.64B 10-K · filed 2018-02-27 | $2.37B 10-Q · filed 2016-05-06 | $11.94B derived: sum of 2 quarters · filed 2018-02-27 | $14.26B derived: sum of 3 quarters · filed 2018-02-27 | $16.53B derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2015-12-31 | $2.30B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $4.62B derived: sum of 2 quarters · filed 2018-02-27 | $6.89B derived: sum of 3 quarters · filed 2018-02-27 | $8.68B 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $2.32B 10-Q · filed 2016-10-28 | $4.59B derived: sum of 2 quarters · filed 2016-10-28 | $6.38B 10-Q · filed 2016-10-28 | $7.89B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $2.27B 10-Q · filed 2016-07-29 | $4.06B 10-Q · filed 2016-07-29 | $5.58B derived: sum of 3 quarters · filed 2017-02-27 | $7.13B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $1.79B 10-Q · filed 2016-05-06 | $3.31B derived: sum of 2 quarters · filed 2017-02-27 | $4.86B derived: sum of 3 quarters · filed 2017-02-27 | $6.37B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $1.51B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $3.06B derived: sum of 2 quarters · filed 2017-02-27 | $4.58B derived: sum of 3 quarters · filed 2017-02-27 | $6.01B 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | $1.55B 10-Q · filed 2015-10-30 | $3.07B derived: sum of 2 quarters · filed 2015-10-30 | $4.50B 10-Q · filed 2015-10-30 | |||||
| 2014-06-30 | $1.52B 10-Q · filed 2015-07-30 | $2.95B 10-Q · filed 2015-07-30 | ||||||
| 2014-03-31 | $6.01B 10-K · filed 2017-02-27 | $1.43B 10-Q · filed 2015-05-04 | ||||||
| 2013-12-31 | $5.81B 10-K · filed 2016-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |